RU2247389C2 - Способ идентификации индивидуума с риском сосудистого и ракового заболевания - Google Patents

Способ идентификации индивидуума с риском сосудистого и ракового заболевания Download PDF

Info

Publication number
RU2247389C2
RU2247389C2 RU2002107982/15A RU2002107982A RU2247389C2 RU 2247389 C2 RU2247389 C2 RU 2247389C2 RU 2002107982/15 A RU2002107982/15 A RU 2002107982/15A RU 2002107982 A RU2002107982 A RU 2002107982A RU 2247389 C2 RU2247389 C2 RU 2247389C2
Authority
RU
Russia
Prior art keywords
concentration
homocysteine
serum
pgi
individual
Prior art date
Application number
RU2002107982/15A
Other languages
English (en)
Russian (ru)
Other versions
RU2002107982A (ru
Inventor
Пентти СИППОНЕН (FI)
Пентти Сиппонен
Матти ХЯРКЕНЕН (FI)
Матти Хяркенен
Осмо СУОВАНИЕМИ (FI)
Осмо Суованиеми
Original Assignee
Биохит Ойй
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Биохит Ойй filed Critical Биохит Ойй
Publication of RU2002107982A publication Critical patent/RU2002107982A/ru
Application granted granted Critical
Publication of RU2247389C2 publication Critical patent/RU2247389C2/ru

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/82—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806—Determination of free amino acids
    • G01N33/6812—Assays for specific amino acids
    • G01N33/6815—Assays for specific amino acids containing sulfur, e.g. cysteine, cystine, methionine, homocysteine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
RU2002107982/15A 1999-08-31 2000-08-30 Способ идентификации индивидуума с риском сосудистого и ракового заболевания RU2247389C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI19991836 1999-08-31
FI991836A FI107808B (fi) 1999-08-31 1999-08-31 Menetelmä verisuoni- sekä syöpäsairaudelle riskialttiin yksilön identifioimiseksi

Publications (2)

Publication Number Publication Date
RU2002107982A RU2002107982A (ru) 2003-11-10
RU2247389C2 true RU2247389C2 (ru) 2005-02-27

Family

ID=8555217

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2002107982/15A RU2247389C2 (ru) 1999-08-31 2000-08-30 Способ идентификации индивидуума с риском сосудистого и ракового заболевания

Country Status (7)

Country Link
EP (1) EP1210452A1 (enExample)
JP (1) JP2003508059A (enExample)
CN (1) CN1158389C (enExample)
AU (1) AU6845600A (enExample)
FI (1) FI107808B (enExample)
RU (1) RU2247389C2 (enExample)
WO (1) WO2001016356A1 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2312356C2 (ru) * 2005-12-28 2007-12-10 Федеральное государственное лечебно-профилактическое учреждение "Научно-клинический центр охраны здоровья шахтеров" Федерального агентства по энергетике РФ Способ оценки степени тяжести ишемического инсульта у лиц в возрасте до 50 лет
RU2413940C2 (ru) * 2009-02-02 2011-03-10 Государственное образовательное учреждение высшего профессионального образования Воронежская государственная технологическая академия Способ определения витамина b12 в водных растворах
RU2453001C1 (ru) * 2010-10-18 2012-06-10 Государственное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию" Способ коррекции гипергомоцистеин индуцированного дефицита оксида азота l-норвалином в эксперименте

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114924016B (zh) * 2022-04-28 2024-03-08 中国医学科学院北京协和医院 同时检测硫酸化及未硫酸化胃泌素g17的方法及其检测试剂盒

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996015456A1 (en) * 1994-11-16 1996-05-23 Locus Genex Oy Method for screening the risk of gastric cancer

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996015456A1 (en) * 1994-11-16 1996-05-23 Locus Genex Oy Method for screening the risk of gastric cancer

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Болезни органов кровообращения. Лечение опухолевых заболеваний. Справочник практического врача. Изд-во "БАЯН", 1994, с.34-52, 60-95. *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2312356C2 (ru) * 2005-12-28 2007-12-10 Федеральное государственное лечебно-профилактическое учреждение "Научно-клинический центр охраны здоровья шахтеров" Федерального агентства по энергетике РФ Способ оценки степени тяжести ишемического инсульта у лиц в возрасте до 50 лет
RU2413940C2 (ru) * 2009-02-02 2011-03-10 Государственное образовательное учреждение высшего профессионального образования Воронежская государственная технологическая академия Способ определения витамина b12 в водных растворах
RU2453001C1 (ru) * 2010-10-18 2012-06-10 Государственное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию" Способ коррекции гипергомоцистеин индуцированного дефицита оксида азота l-норвалином в эксперименте

Also Published As

Publication number Publication date
WO2001016356A1 (en) 2001-03-08
EP1210452A1 (en) 2002-06-05
CN1158389C (zh) 2004-07-21
FI107808B (fi) 2001-10-15
FI19991836L (fi) 2001-02-28
JP2003508059A (ja) 2003-03-04
AU6845600A (en) 2001-03-26
CN1371427A (zh) 2002-09-25

Similar Documents

Publication Publication Date Title
Ueland et al. Total homocysteine in plasma or serum: methods and clinical applications
JP2579434B2 (ja) コバラミンおよび葉酸の欠乏を検出および区別する方法
Still et al. ACP Broadsheet No 152: March 1998. Clinical implications of plasma homocysteine measurement in cardiovascular disease.
Nexø et al. How to diagnose cobalamin deficiency
EP2894477A1 (en) Method for determining breast cancer
KR100394940B1 (ko) 간 질환 진단을 위한 혈중 아사이알로당단백질양의측정방법 및 측정용 킷트
Rasmussen et al. Methylmalonic acid concentrations in serum of normal subjects: biological variability and effect of oral L-isoleucine loads before and after intramuscular administration of cobalamin
Sheabar et al. Quantitative analysis of aflatoxin-albumin adducts
RU2247389C2 (ru) Способ идентификации индивидуума с риском сосудистого и ракового заболевания
US20030124616A1 (en) Homocysteinylated transthyretin
US20240393353A1 (en) Biomarker for cancer diagnosis and use thereof
DE60217665T2 (de) Verfahren zur Bestimmung der Aktivität von Thymidinkinase-1 und dessen Verwendung
Besch et al. Measurement of insulin in human sera using a new RIA kit. 1. Insulin determination in the absence of insulin antibodies—conventional assay and micro Modification2
Liu et al. Immunochemical determination of LDH-1
EP3234104A2 (en) Accurate assay measurement of hydrophobic haptenic analytes
RU2224258C2 (ru) Способ идентификации индивидуума, у которого существует риск необратимых неврологических повреждений, включающий в себя этапы количественного определения концентрации пепсиногена i (pgi) и витамина в12
JP2003508059A5 (enExample)
EP0965043A1 (en) Detection of cardiac muscle necrosis by immunoassay and appropriate antibodies therefor
Tateishi et al. Stability of bombesin in serum, plasma, urine, and culture media.
Zappacosta et al. Comparing different methods for homocysteine determination
Finglas et al. Validity of dual-label stable isotopic protocols and urinary excretion ratios to determine folate bioavailability from food
US7727972B2 (en) Methods for determining absorption of cobalamin or analogues thereof
Hamilton et al. Investigation of megaloblastic anaemia: cobalamin, folate and metabolite status
Kurtz et al. Inexpensive double-antibody fluoroimmunoassay for aminoglycoside antibiotics, phenytoin, and theophylline in serum.
Mourvaki et al. Performance comparison of three assay methods used in fasting and postmethionine load plasma homocysteine determinations from patients with vascular disease